NCT04151342 CAnadian CAncers With Rare Molecular Alterations (CARMA) - Basket Real-world Observational Study (BROS) Status RECRUITING Phase N/A
NCT04149067 Study of Real-world Evidence With SGLT2i (Dapagliflozin) and DPP4i (Sitagliptin) in Type 2 Diabetes Patients in Spain Status COMPLETED Phase N/A
NCT04142424 A Study to Understand the Safety, Tolerability, and Activity of Drug in Body Over a Period of Time of AZD2693, in Subjects of Non-Childbearing Potential in Overweight But Otherwise Healthy Subjects, and Healthy Chinese and Japanese Subjects Status COMPLETED Phase PHASE1
NCT04141800 Spanish Study of Hyperkalaemia Incidence and Prognosis in Patients With Heart Failure and Reduced Ejection Fraction Status COMPLETED Phase N/A
NCT04136171 CARDIO-TTRansform: A Study to Evaluate the Efficacy and Safety of Eplontersen (Formerly Known as ION-682884, IONIS-TTR-LRx and AKCEA-TTR-LRx) in Participants With Transthyretin-Mediated Amyloid Cardiomyopathy (ATTR CM) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04128332 Pre-operative Stereotactic Ablative Body Radiotherapy Followed by Immediate Surgery for Pancreatic Cancer Status COMPLETED Phase NA
NCT04126499 Study to Characterise Patients Receiving Benralizumab in the Framework of an Individualized Access Program in Spain Status COMPLETED Phase N/A
NCT04125290 US Post-Marketing Safety Study of Moxetumomab Pasudotox-tdfk (LUMOXITI) Status TERMINATED Phase N/A
NCT04121910 A Study to Evaluate the Amount of Drug That Becomes Available in the Blood Circulation When Savolitinib is Administered Alone and in Combination With Itraconazole Status COMPLETED Phase PHASE1
NCT04118842 A Study in Healthy Subjects to Assess the Pharmacokinetics of Savolitinib When Administered Alone and in Combination With Rifampicin Status COMPLETED Phase PHASE1
NCT04116047 CompARE: Escalating Treatment of Intermediate and High-risk Oropharyngeal Cancer (OPC) Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT04108481 Immunotherapy With Y90-RadioEmbolization for Metastatic Colorectal Cancer Status TERMINATED Phase PHASE1
NCT04106115 DURvalumab in Combination With S-488210/S-488211 vAccine in Non-muscle Invasive Bladder CancEr Status RECRUITING Phase PHASE1/PHASE2
NCT04105153 Real-world Analysis of Workup at Disease Progression and Implementation of Osimertinib for EGFR+ NSCLC Status COMPLETED Phase N/A
NCT04090580 Impact on Glycemic Variability in Newly Onset T2DM Patients Initiating Dapagliflozin Plus Metformin Versus Metformin Alone Status COMPLETED Phase PHASE3
NCT04089553 An Open-label, Phase II Study of AZD4635 in Patients With Prostate Cancer Status COMPLETED Phase PHASE2
NCT04088032 Neoadjuvant Study of Abemaciclib, Durvalumab, and an Aromatase Inhibitor Early Stage Breast Cancer Status WITHDRAWN Phase EARLY_PHASE1
NCT04087590 Impact of Inhaled PT003 on Complexity and Variability of Tidal Breathing and Oscillatory Mechanics in Stable COPD Patient Status TERMINATED Phase PHASE2